Your browser is no longer supported. Please, upgrade your browser.
OSUR OraSure Technologies, Inc. daily Stock Chart
OraSure Technologies, Inc.
Index- P/E94.80 EPS (ttm)0.20 Insider Own1.50% Shs Outstand61.93M Perf Week8.19%
Market Cap1.41B Forward P/E- EPS next Y-0.06 Insider Trans0.00% Shs Float57.77M Perf Month59.32%
Income12.60M PEG4.74 EPS next Q-0.10 Inst Own82.20% Short Float10.80% Perf Quarter23.23%
Sales156.10M P/S9.02 EPS this Y527.00% Inst Trans1.30% Short Ratio3.72 Perf Half Y168.96%
Book/sh4.69 P/B4.08 EPS next Y71.40% ROA3.80% Target Price16.00 Perf Year132.12%
Cash/sh2.26 P/C8.47 EPS next 5Y20.00% ROE4.20% 52W Range5.23 - 19.14 Perf YTD138.48%
Dividend- P/FCF563.01 EPS past 5Y39.30% ROI4.50% 52W High0.05% Beta0.66
Dividend %- Quick Ratio7.60 Sales past 5Y7.70% Gross Margin59.40% 52W Low266.16% ATR0.87
Employees472 Current Ratio8.50 Sales Q/Q5.00% Oper. Margin9.20% RSI (14)77.07 Volatility5.52% 5.50%
OptionableYes Debt/Eq0.01 EPS Q/Q-123.50% Profit Margin8.10% Rel Volume0.64 Prev Close18.15
ShortableYes LT Debt/Eq0.00 EarningsAug 05 AMC Payout0.00% Avg Volume1.68M Price19.15
Recom2.70 SMA2022.40% SMA5045.43% SMA20088.52% Volume1,070,916 Change5.51%
Jun-25-20Initiated Lake Street Buy $19
Apr-21-20Resumed Stephens Equal-Weight $14
Oct-23-18Resumed Raymond James Mkt Perform
Jul-16-18Downgrade Stephens Overweight → Equal-Weight
Nov-02-17Downgrade Jefferies Buy → Hold
Feb-09-17Upgrade Raymond James Mkt Perform → Outperform
Jun-13-16Downgrade Raymond James Outperform → Mkt Perform
Nov-05-15Reiterated Mizuho Buy $12 → $8
May-07-15Downgrade JMP Securities Mkt Outperform → Mkt Perform
Jan-23-15Reiterated Mizuho Buy $10 → $12
Jun-12-14Reiterated Canaccord Genuity Buy $10 → $11
Jun-11-14Reiterated Mizuho Buy $9 → $10
Dec-21-12Initiated Mizuho Buy $9
Aug-08-12Upgrade Barrington Research Mkt Perform → Outperform $12.50
Jul-05-12Downgrade Barrington Research Outperform → Mkt Perform
Mar-27-12Initiated JMP Securities Mkt Outperform $15
Mar-21-12Upgrade MLV & Co Hold → Buy $11 → $13
Feb-09-12Downgrade MLV & Co Buy → Hold $11
Jul-01-11Resumed Barrington Research Outperform $10
Nov-30-10Initiated Barrington Research Outperform $8
Jul-31-20 12:15PM  
Jul-29-20 12:33PM  
Jul-22-20 06:00AM  
Jun-25-20 08:00AM  
Jun-23-20 12:52PM  
Jun-17-20 07:00AM  
Jun-16-20 08:21AM  
Jun-10-20 08:00AM  
Jun-08-20 08:00AM  
Jun-03-20 08:50PM  
Jun-02-20 11:15PM  
Jun-01-20 04:01PM  
May-29-20 07:00AM  
May-26-20 06:00AM  
May-22-20 07:00AM  
May-15-20 06:00AM  
May-14-20 06:00AM  
May-12-20 08:00AM  
May-07-20 10:31AM  
May-06-20 04:00PM  
May-05-20 06:00AM  
May-04-20 06:00AM  
May-02-20 10:56AM  
Apr-29-20 12:33PM  
Apr-09-20 06:00AM  
Apr-08-20 01:18PM  
Apr-06-20 06:00AM  
Apr-02-20 09:35AM  
Mar-27-20 07:20AM  
Mar-19-20 09:17AM  
Feb-26-20 06:00AM  
Feb-21-20 10:04AM  
Feb-20-20 07:06AM  
Feb-19-20 05:15PM  
Feb-12-20 12:31PM  
Jan-30-20 08:50AM  
Jan-29-20 12:31PM  
Jan-22-20 06:00AM  
Jan-08-20 06:00AM  
Jan-07-20 12:21PM  
Dec-17-19 09:00AM  
Dec-10-19 12:42PM  
Dec-09-19 06:13PM  
Nov-28-19 01:22AM  
Nov-26-19 08:00AM  
Nov-06-19 08:15PM  
Oct-31-19 10:28AM  
Oct-30-19 10:33AM  
Oct-28-19 06:00AM  
Oct-22-19 06:00AM  
Oct-08-19 12:07PM  
Sep-12-19 11:26AM  
Aug-20-19 07:44AM  
Aug-19-19 08:00AM  
Aug-14-19 09:00AM  
Aug-07-19 09:24AM  
Aug-06-19 06:15PM  
Jul-31-19 06:00AM  
Jul-30-19 10:38AM  
Jul-28-19 09:16AM  
Jul-25-19 06:00AM  
Jul-10-19 06:20AM  
Jun-26-19 05:00PM  
Jun-22-19 09:19AM  
Jun-14-19 04:00PM  
Jun-13-19 06:00AM  
Jun-11-19 04:35PM  
Jun-07-19 08:21AM  
Jun-04-19 08:07AM  
May-29-19 06:00AM  
May-17-19 07:46AM  
May-15-19 06:00AM  
May-14-19 06:00AM  
May-09-19 11:23AM  
May-08-19 06:25PM  
May-05-19 08:16PM  
May-01-19 10:33AM  
Apr-30-19 07:24AM  
Apr-25-19 08:00AM  
Apr-17-19 06:00AM  
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. The company operates in two segments, OSUR and DNAG. The company also offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company's principal products include OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, and OraSure QuickFlu Rapid Flu A&B test; OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; tuberculosis products; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands; microbiome collection products; and GenoFIND services, a suite of genomic services. In addition, the company manufactures and sells kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. Further, it provides medical devices for the removal of benign skin lesions by cryosurgery or freezing; immunoassay tests and reagents for insurance risk assessment, substance abuse testing, and forensic toxicology applications; an oral fluid Western blot confirmatory test for confirming positive HIV-1 test; and Q.E.D. rapid point-of-care saliva alcohol test. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies, Inc. was founded in 2000 and is based in Bethlehem, Pennsylvania.